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Abstract
Homoeopathy is an alternative medical system proposed by Samuel Hahnemann in the 
eighteenth century. It uses highly diluted and agitated substances that derived from plants, 
minerals or animals, which have shown to be effective in human medicine, agronomy, vet-
erinary, and as a novelty, in marine aquaculture. Aquacultural homoeopathy has developed 
rapidly in recent years, partially motivated by the misuse of powerful drugs (hormones, 
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antibiotics, disinfectants) that when solving a problem generate undesirable side effects. 
In the last 10 years, scientific articles have been published on its application in freshwater 
fish native to Brazil, obtaining beneficial effects on growth, survival, hepatosomatic index, 
development of muscle fibres and lipid content in muscle. At Centro de Investigaciones 
Biológicas del Noroeste (CIBNOR, Mexico: www.cibnor.mx), we have studied the effects of 
homoeopathy to improve the culture of economically important marine species of molluscs, 
fish and shrimp. In this chapter, we show a selection of different research with preliminary 
or advanced results, related to the use of homoeopathy and its impact on zootechnic, bio-
chemical, genomic and transcriptomic parameters in marine molluscs, fish and crustaceans. 
The results obtained suggest that homoeopathy is an eco-friendly alternative applicable in 
aquaculture industry to improve various productive and health aspects.
Keywords: homeopathic medicine, marine molluscs, crustaceans and fish, growth, 
survival and biomass production, physiology and reproduction, genomic, metagenomic 
and transcriptomic response
1. Introduction
Aquaculture has become a dynamic industry in constant development with the fastest growth 
food production sector of animal origin, even at a higher rate than human population, which 
could provide half of the fish consumption worldwide. However, its great development has 
turned out into great problems and challenges, based mainly on hyper-intensive production 
systems where the common denominator is high cultivation densities that generally cause 
physiological stress. Acute or chronic stress acts in a synergistic way to other environmental 
factors, negatively impacting productive parameters or increasing sensitivity to diseases pro-
duced by opportunistic pathogens as bacteria and viruses. Altogether finally translates into 
great economic losses to producers. Among the solutions for these problems is the use of expen-
sive immunostimulant substances, so producers have opted to use and misuse antibiotics and/
or prophylactics to treat stress and its consequences. Antibiotics promote the resistance of target 
organisms and leave residues in the environment and in tissues, which has become a public 
health problem in some countries [1, 2]. For this reason, alternatives have been sought such as 
the use of probiotics [3], phytobiotics [4], and recently homoeopathy that has been investigating 
as a novel alternative to improve various productive aspects in the culture of aquatic organ-
isms [5]. Homoeopathy is a branch of universal medicine based on the Law of Similars also 
expressed as “principle of like” (Similia Similibus Curentur = Like cures Like), and it is applied 
in ultra-diluted and succussed minimal doses. It is assumed that a substance that is applied in 
high doses (massively) generates a pathological symptomatology, so if it is applied in minimum 
doses (obtained by serial dilution and agitation), it can in turn cure it [6]. Homoeopathy derives 
from a Hippocratic medical concept proposed by the German physician Samuel Hahneman 
(1755–1843), who developed decimal (D; 1: 9), centesimal (C; 1: 99) millesimal (M; 1: 999) dilu-
tions and other medicines, which are actually known as homoeopathic “dilutions” or “dyna-
misations.” This process consists of serial dilution of mineral, plant and animal concentrate 
materials in water-ethanol vehicle, and vigorous agitation or “succussion” [7]. The starting point 
to obtain a certain dynamisation is a concentrate or Mother Tincture (MT), which is an alcoholic 
extract prepared from plants, animals, minerals, and even nanoparticulate metals [7]. In spite 
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of its high dilution, it is possible to detect nanoparticles of the “ponderable active principle” 
(MT) in the dynamisations, even in high centesimal dilutions despite the fact that according 
to Avogadro’s theory, they should not have a single molecule of MT [8]. Therefore, re-naming 
homoeopathy as “Adaptative Network Nanomedicine” has been recently proposed [9].
Homoeopathy has the peculiarity of stimulating the self-recovery of dynamic homeostasis 
when it has been lost due to exogenous and/or endogenous factors. Therefore, it does not 
focus on “the disease” but on the manifestations and intrinsic defence mechanisms of the 
“patient.” It offers “signals” of systemic action to the treated individual to promote its self-
regulation to recover homeostasis, and as it uses ultra-diluted minimal doses, it does not leave 
residues in the organism or in the environment. As a counterpart, the other medicine known 
as “allopathy” derives from a galenic concept based on the “principle of opposites” and the 
application of massive doses of various chemotherapeutic agents officially classified as anti-
microbial, anti-viral, anti-inflammatory, anti-spasmodic, anti-histaminic, anti-fever and other 
“anti” drugs. Homoeopathic medicines can be administered to any living being, including 
terrestrial and aquatic plants, wild animals in captivity and breeding, as well as freshwater 
and marine species of commercial interest [7]. It has been widely used in human, animal 
and plant medicine because it induces specific responses and increases immunity, favouring 
resistance to pathogens under stressing situations, promoting a better post-infection recovery 
and improving internal dynamic homeostasis [5, 6, 10].
In Mexico, homoeopathy is recognised as a therapy of alternative medicine, and its practice 
was authorised by presidential decree in July 31, 1895; today its study and practice is offi-
cially recognised in the general health law (2015), and only health professionals can prescribe 
homoeopathic medicines, which must have an official code. This is the way homoeopathic 
medicines are differentiated from products like herbs for infusion and herbal remedies. In 
countries such as Brazil, there are homoeopathic medicines exclusively for veterinary use, 
for marine and freshwater fishes, registered with the Ministry of Agriculture. Important and 
promising results have been reported in freshwater organisms, mainly Nile Tilapia Oreochromis 
niloticus and Pacu Piaractus mesopotamicus [11–13]. Taking into account these antecedents, this 
chapter compiles not only the experimental results obtained in marine organisms, such as 
molluscs, fish and crustaceans when treated with commercial homoeopathic medicines for 
human use and approved by Federal Health Law and Health Ministry of México but also 
other ones that have been designed and developed at Centro de Investigaciones Biológicas del 
Noroeste (CIBNOR) in La Paz, Baja California Sur, Mexico.
For the purposes of this chapter, commercial drugs for human use have been utilised in the 
form of liquid hydro-alcoholic dynamisations (Similia® Laboratories, Mexico), injectable 
aqueous dynamisation (Rubiopharma®, Mexico) or sugar impregnated with homoeopathic 
complexes (Arenales Homoeopathy®, Brazil). They were considered “stock dynamisations,” 
from which the respective “work dynamisations” were obtained through a serial process of 
dilution-succussion decimal or centesimal. Other non-commercial medicines were designed 
and developed at CIBNOR, from bacterial products (nosodes). This chapter deals with unitary 
or complex laboratory treatments used and registered with the Mexican Ministry of Health, 
such as Similia® and Rubiopharma® and a Cuban drug of Labiofam®, which will be described 
as follows: Passiflora incarnata, Valeriana officinalis, Ignatia amara and Zincum valerianicum of 
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Similia® (PaV); Cyme-Heel, Gal-Heel, Hepa-Heel, Mucs-Heel and Chol-Heel of Rubiopharma® 
(INM); Endecto (END) and Infecçoes (INF) of Arenales Homoeopathy®; Phosphoric acid (PhA), 
Phosphoric acid (AcF), Silicea terra (SiT), Sodium methasilicate (MsS), Scorpion toxin Vidatox® 
(ViT); Calcium sulphuricum (CaS); Hepar sulphuris (HeS), Ferrum phosphoricum (FeP); Zincum 
phosphoricum (ZiP); Magnesium phosphoricum (MaP), Mercurius solubilis (MeS). Also, other 
nosode-type homoeopathic medicines from Vibrio compounds (ViP, ViA) were applied. These 
and other nosode type HOM-products have been designed by CIBNOR that is processing 
the respective trademark and industrial property titles (Office for industrial protection and 
technology transfer; OTT-CEPAT/CIBNOR; www.cibor.gob.mx). Ethanol (ET) and no-HOM 
nor ethanol (NT) were used as control treatments. Homoeopathic medicines (HOM) were 
sprinkled on balanced food or inert sugar pills or added directly to culture seawater.
2. Effects of homoeopathy in marine species
2.1. Mollusc
2.1.1. Catarina scallop (Argopecten ventricosus)
The production of mollusc bivalves around the world is still challenged every year by the 
propagation and emergence of new diseases. Scallops are especially susceptible to epizootic 
pathogenic bacteria in the hatchery, mainly those related to Vibrio spp. and Aeromonas spp. 
[14]. Four experiments described below were performed with A. ventricosus.
Trial 1. To assess the effects of homoeopathic treatments (HOM treatments) in the immune 
system of Catarina scallop A. ventricosus, an experimental design was applied at CIBNOR 
during nursery management with five homoeopathic treatments and three controls, four rep-
licates each. Juveniles were placed in recirculating upwelling nursery units (40 l), each one 
with four PVC upwelling cylinders for 21 days. Continuous aeration and a microalgal food 
mix 1:1 (Isochrysis galbana - Chetoceros calcitrans; 150,000 cel ml−1) were provided. The follow-
ing HOM treatments and controls were applied: ViP (T1), ViA (T2), PhA Metasilicate (T3), 
PhA-SiT (T4), ViT (T5), dynamised ET (T6), diluted ET (T7) and NT nor ethanol added (T8).
At the end of the assay, mainly nosodes (ViP, ViA) formulated from pathogenic bacterial com-
pounds, stimulated a significant (p < 0.05) growth rate and increased haemocyte count which 
were counted using three images at 100X from scallops tissue were processed by Image Pro 
Plus 6.0 to count the number of haemocytes in a tissue area (0.21 mm2). Haemocytes count was 
1–3 times higher than controls (Table 1). These results suggested immune system enhance-
ment by the action of HOM treatments because it is known they stimulate enzymatic activity 
of superoxide dismutase (SOD) and catalase (CAT) related with antioxidant responses of the 
organisms during oxidative stress [15]. The proliferation of haemocytes is related to activa-
tion of immune response because they are the primary cells responsible to protect organisms 
against infections [16]. Antioxidant activity increases have also been linked to improving 
survival when organisms are challenged against stressful conditions [16–18]. These findings 
make it clear that HOM treatments can activate a quantifiable biological response on the 
immune and antioxidant system in juvenile scallop A. ventricosus.
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Trial 2. To compare between homoeopathy and antibiotic efficiency in A. ventricosus juveniles, 
an experimental design was performed by triplicate (6 treatments and 18 replicates, 120 seeds 
each replicate) at CIBNOR for 21 days. Juveniles (4.14 ± 0.06 mm; 13.33 ± 0.03) received PaV-
Pha (T1), PaV-Sit (T2) as HOM treatments, ampicillin AMP (T3) as antibiotic treatment, and 
ethanol ET (T4) and NT (T5) as control treatment. Liquid treatments were applied (100 μl l−1 
for homoeopathy and 10 ppm for antibiotic) after seawater exchange every 48 h and before 
feeding scallops. Evaluations were performed for growth in height (mm), total wet weight of 
the shell (mg), biochemical flesh composition (mg g−1) and SOD activity. Thirty juveniles were 
taken at random from each replica at 7, 14 and 21 days to measure size and total wet weight 
and to determine absolute growth in height and weight (mm, mg) for each treatment.
Juveniles grew significantly more in size with HOM T1 (6.22 ± 0.11 mm; 0.05 mm d−1) and T2 
(6.99 ± 0.09 mm; 0.08 mm d−1) compared with NM (T5) (5 ± 0.02 mm; 0.02 mm d−1). A significant 
increase in total wet weight was recorded with HOM T2 (41.16 ± 0.35mg; 1.3 mg d−1) compared 
to NT group T5 (24.33 ± 0.10 mg; 0.5 mg d−1). Survival was 100% in all treatments and their 
replicates (Figure 1).
Haemocyte count Growth rate (μm day−1)
Initial 19 ± 0.38 
e
T1 44 ± 0.54 
a
117 ± 1.32 
a
T2 41 ± 0.57 
b
108 ± 0.97 
a
T3 34 ± 0.75 
c
53 ± 6.31 
c
T4 24 ± 0.40 
d
94 ± 1.38 
b
T5 31 ± 0.32 
c
36 ± 5.83 
d
T6 21 ± 0.87 
e
14 ± 0.40 
e
T7 22 ± 1.13 
de
34 ± 0.06 
d
T8 16 ± 0.60 f 20 ± 0.14 e
Numbers show mean ± standard error. Identical lowercase letters denote lack of significant differences between 
treatments at p < 0.05.
Table 1. Haemocyte count and growth rate in Argopecten ventricosus spat treated with homoeopathic medicines for 21 days.
Figure 1. Growth in size (μm day−1) (left) and weight (mg day−1) (right) of juvenile Catarina scallop Argopecten ventricosus 
treated with homoeopathic medicines.
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Trial 3. As a continuation of Trial 2, once the previous experiment (21 days) was completed, a 
pathogen challenge was performed at CIBNOR with those treated juvenile scallops. About 30 
juveniles were randomly selected from each previous treatment (in duplicate) and challenged 
with a pathogenic strain of Vibrio alginolyticus (CAIM57: www.ciad.mx). An initial single dose 
(1 × 107 CFU ml−1) was provided as based on the mean lethal dose (LD
50
) determined by the 
Probit method and based on the dose–response model described by Finney [19]. To obtain 
greater clarity in the results, in addition to the groups previously treated PaV-PhA (T1), PaV-
SiT (T2), antibiotic AMP (T3) and ET (T4), two new groups that did not receive any previous 
treatment were included. First, a new group was infected with CAIM57 and defined as posi-
tive control (CTRL +), and another new group was not infected and defined as negative control 
(CTRL -). Survival (%) of juveniles was evaluated at 0, 24, 48, 72 and 120 h after infection, and 
the activity of SOD before infection at 48, 72 and 96 h post-infection was determined. For each 
treatment, soft tissues (100 mg) from six juveniles were weighted and 500 μl phosphate buffer 
(pH 7.5) were added. The tissues were homogenised and centrifuged at 9327 × g for 10 min 
at 4°C, recovering the supernatant and storing it at −20°C until further analysis. SOD activ-
ity was determined with a commercial kit (SOD Assay Kit #19160, Sigma-Aldrich). Results 
were expressed as an indirect measure of SOD activity as a per cent of the water-soluble 
tetrazolium salt formazan complex inhibition. During the challenge, no water changes were 
made. All juvenile scallops not treated but challenged (CTRL +) died at 72 h while untreated 
and unchallenged scallops attained the highest survival (95%). The HOM-treated scallops 
also survived the challenge; T1 scallops attained 85 versus 40% survival in those treated with 
antibiotic (T3). Finally, the SOD activity increased significantly with respect to the other treat-
ments and controls in the juveniles of the HOM T1 (81%), 72 h post-infection.
Trial 4. To assess the effects of HOM treatments on the microbial communities of the gastro-
intestinal tract (GIT) of juvenile A. ventricosus an experimental design was applied at CIBNOR 
during nursery management with five homoeopathic treatments and three controls, four 
replicates each. Juveniles were placed in recirculating upwelling nursery units (40 l) each one 
with four PVC upwelling cylinders for 21 days; the following HOM treatments and controls 
were applied: ViP-ViA/a (T1), ViP-ViA/b (T2), AcF-MsS (T3) PhA-SiT (T4), ViT (T5), ET (T6), 
and NT (T7). At the end of the experiment, eight scallops were randomly taken from each 
replica and washed, removed fouling organisms of external sides of shell and sprayed with 
ethanol and dried. Immediately one of the shells was removed and soft tissues dissected to 
isolate the gastrointestinal tract (GIT) of each scallop, which were fixed in RNAlater® (Thermo 
Fisher Scientific, Waltham, MA, USA) and preserved at −20°C. The technique of massive DNA 
sequencing was applied, which is widely used in the study of microbial communities asso-
ciated with biological systems. The bacterial 16S rDNA was extracted according to Garcia-
Bernal et al. [3], amplified for sequencing in the Illumina MiSeq Platform (Illumina, San Diego, 
CA, USA) in a certified Genomic Services Laboratory (www.langebio.cinvestav.mx; Irapuato, 
Guanajuato, México). Afterward, a bioinformatic and statistical analysis of the generated 
database was carried out. Initially, significant differences were detected (p < 0.05) in growth 
rate of shell length (μm d−1) (p < 0.05), with the best results (140 μm d−1) in the HOM T2. The 
groups that received T3 and T5 showed a significantly higher survival rate (p < 0.05) than the 
other groups. Moreover, the dominant phylum was Proteobacteria, followed by Actinobacteria, 
Firmicutes, and Bacteroidetes. The prevalent genera in GIT were Microbacterium, Bacillus, 
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Symbiobacterium and Burkholderia. In general terms, phyla Proteobacteria and Actinobacteria 
play an essential role in immunity and nutrition of invertebrates, and both were dominant in 
juvenile scallop A. ventricosus in all groups treated with HOM.
2.1.2. Horse-mussel (Modiolus capax)
The Horse mussel Modiolus capax is a native species from the Gulf of California with aquacul-
ture potential, but scientific knowledge must be generated to achieve a sustainable production 
[20]. A study was developed at CIBNOR to assess the effect of HOM treatments on gonadal, 
physiological and transcriptomic maturation in M. capax. Microalga and wheat meal were 
used as food for broodstock mussels. The experiment was designed in triplicate (482 adult 
mussels; 60 days) and applied to evaluate three HOM treatments: SiT-CaS-HeS (T1), PhA-FeP-
ZiP (T2), ViP-ViA-ViT (T3), ethanol as positive control (T4), and NT as negative control (T5). A 
sequential sampling in time (days) was made (t
0
, t
30
 and t
60
). The histological analyses showed 
that mussels treated with T1 and T3 attained (t
30
) the best results (p < 0.05) in total weight 
increase, gonadal maturation of 100% females (Figure 2 left), highest frequency of vitellogenic 
and postvitellogenic oocytes and highest oocyte quality according to the total area, theoretical 
diameter and % of ovoplasm. Also, mussels treated with T3 attained the best reproductive 
condition of the females (gonadal coverage area, ovarian maturity index, gonadal develop-
ment index and reproductive potential); however, those receiving T2, increased oogonia 
proliferation and bioenergetic quality of the oocytes (amount of lipids and neutral carbohy-
drates). Histochemical and biochemical analyses revealed that HOM treatments (T1, T2 and 
T3) contributed to increase the overall energy reserves (lipids, carbohydrates and proteins) 
in the ovary, digestive gland and adductor muscle. López-Carvallo et al. [20] using wheat 
enriched di-algal diet, barely reaching gonad to maturity ~ 25% of the M. capax broodstock. 
Thus, we considered that better results in reproductive condition and oocyte quality of the 
species were attained with HOM treatments with respect to control.
On the other hand, a de novo transcriptome characterisation of the ovarian tissue treated with 
homoeopathy was performed using RNAseq. In silico analysis of differential gene expression 
revealed that mussels treated with T3 showed the highest number of differentially expressed 
transcripts (Figure 2 right), and some of them were related to genes that encoded oestrogen 
Figure 2. Frequency of ovarian developmental stages (left) determined by histology and number of genes (right) 
with significant differential expression (p < 0.01) in the ovary transcriptome of broodstock mussels (Modiolus capax) 
conditioned with homoeopathy for gonad maturation. Stage S0 undifferentiated; stage SI Previtellogenesis; stage SII 
Vitellogenesis; stage SIII Posvitellogenic; stage SIV partial spawning; stage SV post spawning; n = 482 mussels. Over-
expressed genes = black bars; under-expressed genes = Grey bars.
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receptors ER and ERR2- like (p < 0.01). Estradiol levels have been reported to have a direct 
influence on gonadic development and oocyte quality in marine bivalves [21] that allowed 
explaining the high reproductive condition found in the mussels that received T3.
This work has provided a de novo transcriptome characterisation for M. capax for the first time 
and together with the evaluation of physiological variables, it constitutes the first research 
about the beneficial effect of homoeopathy in gonadal maturation of the species, which has a 
clear technological applicability during broodstock gonadic conditioning for seed spawning 
and production of the species. It will likely be applicable to other bivalve molluscs with com-
mercial interest.
2.1.3. American oyster (Crassostrea virginica)
The American oyster Crassostrea virginica is an important fishery and aquaculture resource 
in the Atlantic coast in the Caribbean and in the Gulf of Mexico. A commercial oyster labora-
tory is already operating in Centro Ostrícola Tecnológico de Tabasco (COTET), Mexico, and 
homoeopathic medicines were assessed to improve the species culture. HOM treatments were 
assessed in larval culture and settlement and early nursery of on-cultch and cultch-less seed. 
Also, a transcriptomic focus study was developed in adult broodstock oyster. The results 
obtained in six experiments conducted with C. virginica are detailed below.
Trial 1. A study was conducted at CIBNOR to analyse the transcriptomic response to five HOM 
treatments in broodstock oyster C. virginica to understand the response mechanisms that are acti-
vated by these treatments, thus helping to characterise its mode of action. Adult oysters (120 g; 
10–12 cm) from a homogeneous population were conditioned in 80-l plastic boxes provided with 
continuous microalgal food at COTET for 45 days. An experimental design (3 replicates/treat-
ment; 25 oyster/replicate) was applied with four HOM treatments: ViP-ViA (T1), PhA-SiT (T2), 
END (T3), INF (T4) and two controls ET (T5) and NT (T6). As treatment vehicle, fully impreg-
nated inert homoeopathic pills were provided one daily per oyster. Routine techniques of the 
oyster hatchery COTET were applied for conditioning broodstock oyster, and during the trial 
period, two samplings (S
1
 and S
2
) were performed for histological analyses at CIBNOR. As a 
general rule, at the end of the conditioning assay, all conditioned groups were capable of sexu-
ally maturing and spawning in greater or lesser percentage, but specific details were observed 
that allowed to distinguish effects associated to different treatments and controls. Female oysters 
treated with HOM T1 attained the highest frequency of gonad in vitellogesis (48%) and postvi-
tellogenesis (30.2%) stages at first sampling (T1-S
1
) and 16.7% in the second sampling (T1-S
2
). In 
T2-S
2
 oysters, the highest frequency (31.6%) showed at resting (undifferentiated) stage and 30.8% 
post-spawning stage. In ET control T5-S
2
, 38.5% of the female oysters were at resting stage and 
30.8% at post-spawning stage. Oysters of NT control group T6-S
2
 recorded the highest frequency 
(37.5%) in postvitellogenic stage, 31.3% in partial spawning stage and 25% in post-spawning 
stage. In the veterinary HOM T3-S
1
, oysters showed the highest frequency in partial spawning 
stage (71.4%), and in T4-S
1
, the highest frequency (57.1%) was recorded in post-spawning stage. 
It is important to highlight that even when T1, T2, T3 and T6 promoted maturation and spawn-
ing of the male oysters, there were differences between them related to gamete quality since the 
presence of atretic oocytes was seen in some samples of T5 and T6 control treatments. The vet-
erinary HOM T4 seemed to have promoted damage to gametes because abundant degenerative 
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oocytes were observed. To evaluate the quality of the oocytes matured under different treat-
ments, the Sudan Black histochemical technique was used staining the lipid components of the 
cells. The triglyceride lipid index (TLI) was calculated as described by Rodríguez-Jaramillo et al. 
[22], and significant differences were found in oocytes from different treatments and sampling 
times. Lipid content (TLI) was significantly higher (p < 0.0001) in oysters receiving HOM T2 in 
a short conditioning time (S
1
). The rest of the treatments and replicates recorded significantly 
lower TLI values, including Veterinary HOM T3 and T4. A difference between HOM treatments 
lies in the fact that some of them seem to trigger a constant production of new generations of 
oocytes, which may be useful to hatchery purposes because it could be associated to the pos-
sibility of several partial spawning events that could derive into several larval batches and more 
opportunities for seed production.
Trial 2. A study was conducted at CIBNOR to analyse the transcriptomic response to five HOM 
treatments in broodstock oyster C. virginica in order to understand the response mechanisms 
that are activated by these nanomedicines, thus, helping to characterise their mode-of-action. 
About 25 groups of 25 adult oysters (120 g; 10 ± 12 cm), each from a homogeneous population, 
were conditioned in 80-l plastic boxes provided with continuous microalgal food at COTET 
for 45 days. An experimental design with seven different treatments, each one with three 
replicates, was developed to determine the transcriptomic effect of an Actinomycetes strain 
(1 × 106 CFU ml−1 = RL8) and four homoeopathic drug complexes, alone and in combination: 
RL8 (T1), ViP-ViA (T2) PhA-SiT (T3), ViP-ViA + RL8 (T4), PhA-SiT+RL8 (T5) and two control 
groups: ethanol as a positive control (T6) and NT negative control (T7). Five oysters of each 
homoeopathic and control treatments were initially (t
0
) collected and dissected. The rest of the 
oysters were collected and dissected at the end of the experiment (t
45
). Several tissues, including 
mantle, gills, gonad, muscle and digestive gland (DG), were separately placed on snap-frozen 
tubes in RNA later® (Thermo Fisher Scientific, Waltham, MA, U.S.A.) and stored at −80°C. The 
rest of tissue portion were fixed in Davidson solution for histological examination. DG tissues 
fixed in RNA later® (Thermo Fisher Scientific, Waltham, MA, U.S.A.) from five individuals of 
each experimental group were subjected to RNA extraction, for the transcriptomic analysis, 
using Illumina Hiseq 2000 platform (Illumina, San Diego, CA, U.S.A.). The comparison of the 
transcriptome data with the KEGG database indicated that the treatments influenced associ-
ated metabolic pathways in gonadal development and maturation including “Developmental 
process involved in reproduction”, “Meiotic cell cycle process”, “Steroid metabolic process”, 
“Response to oestrogen “and“ Regulation of reproductive process “. These pathways were 
assigned to the KEGG categories of “Developmental process involved in reproduction” which 
was among the most important category, indicating the significance of signal transduction 
systems and endocrine regulation of gonad development and function in C. virginica.
The transcriptome of T2 and T3 had 998 and 881 genes with a significantly increased level 
of expression, respectively, compared to the control (p < 0.05). In T4 and T5, there were 748 
and 789 genes with an increased level of expression, respectively, compared to a separate 
control (p < 0.05). No genes were significantly differentially expressed under T1 compared to 
a separate T2, T3, T4, T5 and controls (p < 0.05). Genes with increased expression following T2 
and T3 were associated with biological processes, including metabolic pathways, ribosomal 
biogenesis, and transport of nitrogen compounds and anions. Following T4 and T5, genes 
with increased expression were involved in metabolism processes related with response to 
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stress, maintaining protein expression. Genes with increased expression following T1 were 
associated with protein kinase A (PKA) signalling that regulates stress responses and mito-
chondrion degradation. The transcriptomic results obtained allowed us to determine that 
homoeopathic treatments expressed transcripts associated with complex biological processes, 
such as reproduction, stress response, cell growth and metabolism of the C. virginica oyster.
Trial 3. An experimental design was applied at COTET for oyster larval culture assessment 
including HOM treatments: SiT (T1), ViT (T2), FeP (T3), MaP (T4) and NT (T5) as a control treat-
ment. The experimental larviculture was performed in 20-l plastic buckets three replicates per 
treatment with filtered seawater, gentle and continuous aeration and the microalga I. galbana 
and C. calcitrans (1:1) as food. Three-day old veliger larvae from a mass production fibreglass 
tank (25 t) were placed in buckets at initial density of 2 larvae ml−1. Liquid HOM treatments were 
added daily to culture water (0.01%). The larviculture test finalised when the first pedivéliger 
larva with a retractable foot was detected but without reaching the final stage of eyed and fully 
developed pediveliger. Analyses were based on initial and three sequential biometrical data from 
30 larvae for each treatment replicate. The HOM larval groups showed better development, sur-
vival and setting efficiency in comparison with untreated groups. As seen in Figure 3, C. virginica 
larvae that received T1 (162 ± 3.08 μm), T2 (162 ± 2.84 μm) and T4 (162 ± 3.13 μm) reached the larg-
est sizes but T5 (145 ± 2.97 μm) reached the lowest sizes, while those larvae receiving T2 reached 
the highest setting efficiency (83 ± 7.98%) and the highest seed survival (36.5 ± 4.9%).
Trial 4. To assess larval settlement, mature eyed pediveliger larvae were obtained by selective 
screening of the same bulk culture tank; then, they were placed in 20-l buckets at a seeding 
density of 0.25 larvae ml−1. The same HOM treatments: SiT (T1), ViT (T2), FeP (T3), MaP (T4) 
and NT (T5) were applied at COTET during the on-cultch setting process. Seawater change, 
aeration and microalgae were provided as food, and 50 clean oyster shells/buckets were 
placed as a natural settlement (cultch) substrate. Liquid homoeopathic treatments were added 
daily to the culture water (0.02% v/v). The results achieved are shown in Figure 3.
Trial 5. A pilot experimental design in triplicate was applied at COTET for larval culture: 
MaP–FeP (T1), SiT–ViT (T2) and NT (T3) as control. Four-day old larvae were placed in nine-
conical fibreglass tanks (750 l) at initial density of 5.33 larvae ml−1 and the microalgae I. galbana 
and C. calcitrans (1:1) was provided as food. Larval growth and harvest of pediveliger larval 
Figure 3. Larval growth (left), larval setting efficiency (Centre) and seed survival in 20-l plastic buckets (right) of 
American oyster Crassostrea virginica, treated with homoeopathic drugs in COTET oyster hatchery.
Aquaculture - Plants and Invertebrates76
biomass was evaluated. Temperature and salinity were maintained in the range of 27 ± 3°C 
and 22 ± 7 psu. Liquid HOM treatments were added daily to culture water (0.01%). Based on 
biometrical data of 30 larvae for each replicate every 48 h, the best results in larval growth 
were obtained with HOM T1, followed by control (T3) and finally by T2 (Figure 4). The high-
est yield in biomass of mature pedivéliger larva (9.29 g) was obtained with HOM T2, followed 
by control T3 (7.42 g) and the lowest production (7.04 g) was obtained with T1 (Figure 4). 
Differential results obtained in this study were attributable to better survival of larvae because 
homoeopathy favours nutrition and assimilation of nutrients, increases stress resistance 
because of high culture density and strengthens the immune system and resistance to attack 
by pathogens [5, 23]. A better survival associated to small sized larvae has been observed 
in other species treated with homoeopathy, such as Panopea globosa and Crassostrea sikamea 
(Mazón-Suástegui et al., unpublished).
Trial 6. An experimental design was applied at COTET for cultch-less spat culture with two 
homoeopathic treatments and one control (four replicates each) in recirculating upwelling 
nursery units (40 l) each one allocating four upwellers of PVC pipe 4″ and airlift devices. As 
HOM treatments, MaP–FeP (T1) SiT–ViT (T2) and NT control (T3) were assessed. Initial seed 
density was set on 4750 spat/upweller and I. galbana and C. calcitrans (1:1) was used as food. 
The total harvest of seed per treatments and replicates (volume) were measured weekly with 
a graduated cylinder. Temperature and salinity were maintained in the range of 27 ± 3°C and 
24 ± 3 psu. Liquid dynamisation treatments were added daily to culture water (0.02%). Based 
on initial and weekly biometrical data of 30 spat for each replicate, the best growth results 
were obtained in the control T3, followed by HOM T2 and finally T1 (Figure 5). In contrast, 
the best results in oyster seed biomass were attained with HOM T1 (268 ml) and T2 (242 ml) 
and the lowest production (236 ml) with control T3 (Figure 5).
Oyster seed receiving HOM treatments grew less in regard to individual size, but an overall 
greater volume of marketable juveniles was harvested, which means that survival was greater 
in HOM treatments. From a commercial hatchery perspective, it is more important to produce 
live seed biomass even if small sized than dead ones. In real production and profitability 
terms, the hatchery could produce and sell more seeds if homoeopathic drugs, such as those 
evaluated in this study were routinely applied. The results in larval settlement and juvenile 
Figure 4. Growth in size (μm) of veliger larvae (left) and harvest of pediveliger larvae (right) of American oyster 
Crassostrea virginica treated with HOM in 750-l conical fibreglass tanks in COTET hatchery.
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nursery confirmed a great potential for aquacultural homoeopathy to strengthen the state-of-
the-art technology in oyster seed production and increase actual productivity and economic 
profitability of the commercial production of the species in the hatchery.
2.1.4. Kumamoto oyster (Crassostrea sikamea)
Kumamoto oyster Crassostrea. sikamea is a highly valuable mollusc species and cultivated in 
several countries, so it is important to generate new knowledge for its culture and alterna-
tive treatments for its management in the laboratory. Four experiments with C. sikamea were 
performed as described below.
Trial 1. An experimental design was applied at CIBNOR for conditioning broodstock with two 
replicates (25 oysters each) in eight plastic boxes (60 l), in which the following treatments were 
tested: ViP-ViA (T1) and PhA-SiT (T2) as HOM treatments, and ET (T3) and NT (T4). As treat-
ment vehicle, fully impregnated inert homoeopathic pills were used, one-a-day per oyster.
Oysters were dissected (30 at t
0
 and 15 from each replicate at t
42
) and soft tissues histologi-
cally processed by haematoxylin and eosin staining to determine gonadic (GI) and digestive 
gland (DG) indexes, reproductive stages and theoretical diameter in oocytes (DT) according 
to Rodriguez-Jaramillo et al. [22] and Barber and Blake [24]. Moreover, significant differences 
were observed (p < 0.05) in GI in broodstock oysters with respect to the initial value (39%), and 
the best results were observed in oysters treated with T2 and T3 (63 and 67%). The highest DI 
was recorded at the beginning of the experiment (60%) and the lowest (p < 0.05) for T2 and T3 
(36 and 32%), which suggested a greater energy storage in the gonad for oocyte maturation 
[24] (Figure 6). A high frequency of organisms in post-spawning and gonadic development 
stage (38 and 52%) was observed at t
0
. At t
42
, the oysters of T2 and T3 showed the highest 
percentage of full sexual maturity (50%) while the greatest number (35 and 40%) of organisms 
in gonadic development stage was observed in T3 and T4 (Figure 6).
Relative to the final DT (35 μm), which was 28 μm at t
0
, no significant differences were recorded 
between HOM-treated and control oysters. However, maturity and undifferentiated stages 
were simultaneously observed in T3 oysters. Since C. sikamea matures and partially spawns 
several times during the same reproductive season, this result suggested a positive effect by 
Figure 5. Growth rate in shell length (μm day−1) (left) and volumetric biomass of harvested seed (right) of American 
oyster Crassostrea virginica seed, receiving HOM treatments in recirculating upwelling nursery units (40 l) at COTET 
hatchery.
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the activation of a new oocyte production cycle associated to HOM T2 (PhA-SiT). In bivalve 
molluscs, an expenditure of digestive gland reserves is associated to gonad development and 
maturation of gametes [24], and T2 was associated to a greater number of sexually mature 
oysters with higher GI and lower ID values. It could be applicable to gonadic conditioning for 
sexual maturation of broodstock oyster at the hatchery.
Trial 2. Once the broodstock assay finished, a subsequent second bioassay was developed 
to evaluate larval performance in two different larval cohorts from HOM-treated spawners 
(T1, T2, T3, T4; three replicates each) and NT spawners (T5, T6, T7, T8; three replicates each). 
The greatest growth in length was recorded in T5 and T6 (217 and 212 μm) and the lowest in 
T3 and T4 (197 and 190 μm). A similar growth pattern was observed in height: the greatest 
in T5–T8 and the lowest in T1–T4. In general, larvae from untreated broodstock grew more. 
Nevertheless, as a counterpart, the general mean survival of larvae from HOM-treated spawn-
ers (T1-T4) was 32.3% higher than those from NT broodstock, and it could be very important 
to improve hatchery seed production. Those differences in larval survival suggested a favour-
able effect of HOM treatments in oocyte quality and then a potential effect in the progeny.
Trial 3. A 35-day experimental design in triplicate (six treatments and 18 replicates, 120 seed 
each replicate) was applied at CIBNOR to compare efficiency of antibiotics against homoeopa-
thy in juvenile C. sikamea. Juveniles (6.13 ± 0.16 mm) were placed in 2-l plastic containers with 
filtered (1 μm) and UV-sterilised seawater (23 ± 1°C; 38 psu), continuous aeration and microalgal 
food. Juvenile oysters received PaV-Pha (T1), PaV-Sit (T2), Pav-MeS (T3) as HOM treatments, 
ampicillin AMP (T4) as antibiotic treatment, and ethanol ET (T5) and NT (T6) as control treat-
ments. Liquid treatments were applied 100 μl l−1 for homoeopathy and 10 ppm for antibiotic 
after exchange of seawater every 48 h and before feeding oysters. Evaluations were performed 
on growth in height (mm), and total wet weight of the shell (mg), biochemical flesh composition 
(mg g−1) and SOD activity. The biochemical composition was determined by triplicate sampling 
at the beginning and end of the trial. Samples were stored at −80°C and then lyophilized, re-
hydrated in 3 ml cold saline solution (35%) and homogenised to obtain crude extracts. Crude 
extracts were processed at CIBNOR laboratory applying traditional and certified techniques, 
which are described by López-Carvallo et al. [20] and Mazón-Suástegui et al. [23]. For SOD anal-
yses, after deep cleaning of shell, soft tissues were dissected and fixed individually in RNAlater® 
Figure 6. Gonadic index (GI) and digestive index (DI) (left) and gonad development (tight) in broodstock oyster 
Crassostrea sikamea conditioned in the laboratory for 42 days. Different letters show significant differences between 
treatments (p < 0.05). Stage 0: Undifferentiated; stage I: Previtellogenesis; stage II: Vitellogenesis; stage III: Posvitellogenic; 
stage IV: Partial spawning; stage V: Post spawning.
Aquacultural Homoeopathy: A Focus on Marine Species
http://dx.doi.org/10.5772/intechopen.78030
79
(Thermo Fisher Scientific, Waltham, MA, USA) at a 1:5 ratio (100 mg tissue: 500 μl RNA-Later®) 
and then preserve it at −20°C. SOD analyses activity was determined with a commercial kit 
(SOD Assay Kit #19160, Sigma-Aldrich). Results were expressed as an indirect measure of 
SOD activity as a per cent of the water soluble tetrazolium salt formazan complex inhibition. 
The juveniles grew significantly more with HOM T1 (9.27 ± 0.18 mm, 0.073 mm day−1) and T3 
(9.36 ± 0.18 mm, 0.076 mm day−1) compared with NT (T6) (8.02 ± 0.23 mm; 0.053 mm day−1), but 
of all treatments, the ET T5 group was the best (10.17 ± 0.31 mm; 0.105 mm day−1). A signifi-
cant increase in total wet weight was recorded with HOM T2 (107.33 ± 6.9 mg, 2.0 mg day−1) 
compared to NT group T6 (76.11 ± 2.8 mg, 1.1 mg day−1) (Figure 7). Survival was 100% in all 
treatments and their replicates. Moreover, the biochemical composition of the juveniles showed 
significant differences in carbohydrates and lipids but not in proteins. The highest amount of 
lipids was obtained with HOM T2 (96.32 ± 1.18 mg g−1) and that of carbohydrates in antibiotic T4 
(27.48 ± 2.27 mg g−1) compared with the NT (T6) (6.96 ± 1.47 mg g−1). At the end of this trial, SOD 
activity was higher in HOM T1 (92%) than control T6 (88%) and antibiotic T4 (84%).
Trial 4. Once the previous experiment was completed, a pathogen challenge was made with 
treated seeds. About 30 juveniles were randomly selected from each previous treatment (in dupli-
cate) and challenged at CIBNOR with a pathogenic strain of V. alginolyticus (CAIM57: www.ciad.
mx). An initial single dose (1 × 106 CFU ml−1) was given as based on the mean lethal dose (LD
50
) 
determined by the Probit method based on the dose–response model described by Finney [19].
To obtain greater clarity in the results, in addition to the groups treated with homoeopathy, 
antibiotic and ethanol, two new groups were included, which did not receive any previous 
treatment; one of which was infected with the pathogen (CTRL +) and another one that 
was not infected with the pathogen (CTRL -). Survival (%) of juveniles was evaluated at 
0, 24, 48, 72 and 120 h after infection and the SOD activity (using a commercial kit; SOD 
Assay Kit #19160, Sigma-Aldrich) of before infection and at 2, 24, 48 and 72 post-infection 
was determined. After being infected with the pathogen, all the juveniles survived and 
no significant differences were observed between treatments and controls with respect to 
SOD activity. Up to date, that result has no coherent explanation yet; unless the species is 
highly resistant, the pathogenic strain has not got sufficient virulence or a wrong (lower) 
dose was applied because 1 × 107 CFU ml−1 was applied to juvenile scallop A. ventricosus by 
Mazón-Suástegui [23].
Figure 7. Growth in size (mm day−1) (left) and total wet weight (mg day−1) (right) in juveniles of the oyster Kumamoto 
Crasssostrea sikamea treated with homoeopathic medicines.
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2.1.5. Geoduck clam (Panopea globosa)
The geoduck clam Panopea globosa is an important marine resource distributed on both coasts of 
the peninsula of Baja California, Mexico. Its cultivation is still in experimental stage and totally 
depending on juveniles produced in the laboratory. As with other bivalves, there are limita-
tions in their production due to mortalities of larvae and seeds, associated with the presence of 
pathogens. This problem has led to the search for new eco-friendly alternatives such as aqua-
culture homoeopathy, which has a positive effect on nutrition, health and immune response of 
bivalve molluscs, shrimp and marine fish [5, 23]. Our study evaluated the effect of various HOM 
treatments on growth, survival and microbiota of the gastrointestinal tract (GIT) of the species. 
Juvenile (spat) P. globosa with an average length of 1.98 ± 0.1 cm were produced in the laboratory 
and provided by the company Acuacultura Robles, a commercial mollusc hatchery located in La 
Paz, B.C.S. Mexico. Clams with an average length of 1.98 ± 0.1 cm were produced and provided 
by the company Acuacultura Robles, acclimatised at CIBNOR and then cultured (21 days) in 
nursery units previously described for A. ventricosus. About 24 upwelling units were used, each 
one with 52 clams and 13 clams per upweller cylinder; the following HOM treatments and 
controls were applied: ViP-ViA/a (T1), ViP-ViA/b (T2), AcF-MsS (T3) PhA-SiT (T4), ViT (T5), 
ET (T6) and NT (T7). Samples were taken at the beginning (t
o
) and end of the experiment (t
1
) by 
randomly selecting eight clams per replica, accounting for a total number of 216. After exter-
nal deep cleaning, soft tissues were dissected to isolate GIT of each clam to fix individually in 
RNAlater® (Thermo Fisher Scientific, Waltham, MA, USA) at a 1:5 ratio (100 mg tissue: 500 μl 
RNA-Later®) and then preserve it at −20°C. The bacterial 16S rDNA was extracted according to 
Garcia-Bernal et al. [3] and amplified using Illumina MiSeq Platform (Illumina, San Diego, CA) 
in a certified Genomic Services Laboratory (www.langebio.cinvestav.mx; Irapuato, Guanajuato, 
México). Afterward, a bioinformatic and statistical analysis of the generated database was car-
ried out. Taking as reference the microbial diversity in the GIT of P. globosa juveniles, the best 
results were obtained with HOM T1, a nosode product developed at CIBNOR. T1 favoured 
dominant abundance of the Proteobacteria phylum and some of its classes as γ-Proteobacteria. 
In that sense, similarities were observed with the microbiota of other marine species, and that 
part of the microbiota found in P. globosa is associated with stimulation of the immune system. 
Overall, the results indicated that the HOM treatments modified the abundance of the microbial 
communities of the species, mainly in the phylotypes related to nutritional processes. On the 
other hand, significant differences were recorded with respect to growth in weight and length 
(p < 0.0001) between the clams that received HOM treatment and the control groups. The high-
est growth in weight was recorded in T3, T4 and T5. The difference in growth in length was 
smaller but equally superior to these HOM treatments. Significant differences (p = 0.019) in 
survival were also observed. The highest value (95%) was recorded in clams with HOM T3 
followed by the NT control group T7 (93%) without homoeopathy or ethanol. In contrast, the 
lowest survival (76%) was observed in T2 and also in the ET control group T6.
2.1.6. Octopus (Octopus bimaculoides)
An experimental design in triplicate (10 juveniles/replicate) was developed in 60-l fibreglass 
units at CIBNOR laboratory to assess growth and survival in juvenile octopus during a 28-day 
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period. This assay was intended to study and compare the effects of fresh crab Callinectes beli-
cosus and squid Dosidicus gigas meat, as raw or thermically processed food (35°C and 60°C). 
Also, a HOM treatment was added to culture water, as a digestive system enhancer to Octopus 
bimaculoides. Two processed food treatments (35°C and 60°C), two HOM treatments (HOM-
35 and HOM-60), and a positive control treatment (unprocessed raw food) were assessed. 
As HOM treatment, PhA-SiT was added directly to culture water alternating each medicine 
every day from Monday to Saturday. Food was provided ad libitum once a day. Wet weight 
(day 0 and 17) and survival percentage (day 17) were recorded for all 15 groups (Table 2). As 
expected for a positive control with a traditionally used raw food, the highest survival was 
attained in juvenile octopus fed on raw meat (97%) but also with HOM-35 (93%) and HOM-60 
(86%) the lowest survival was seen in octopuses fed processed food 60°C without giving them 
HOM treatments (Table 2).
Knowledge concerning octopus culture is recent and scarce even when completing the life 
cycle successfully in captivity which is possible with some species [25]. One of the main 
obstacles to achieve production level is the lack of an industrialised food to be physiologi-
cally and economically viable since to date the only efficient food is fresh flesh or live preys 
[26]. In meal production, raw material goes through aggressive thermal processes that induce 
protein denaturalisation, carbonylation, hydrophobicity and aggregation [27]. Octopus diges-
tive enzymes are sensitive to these effects; therefore, they cannot hydrolyse their substrates, 
reducing food digestibility and octopus growth [28, 29].
Heat treatment to raw crab and squid meat to obtain meal ingredients to formulate a bal-
anced diet is not traditionally preferred because this process denaturalises proteins, reduces 
digestibility and assimilation [28], and lipids can oxidise [30]. Experimental results suggested 
an enhancement of enzymatic function in O. bimaculoides promoted by HOM (PhA-SiT) treat-
ment dissolved into culture water when food was not processed. HOM treatment seemed to 
have increased the digestive capability in juvenile octopus and the assimilability of processed 
food (35°C), but the loss of quality in crab and squid meals in 60°C food could not be compen-
sated by the HOM treatment.
2.2. Crustaceans
2.2.1. White shrimp (Litopenaus vannamei)
The White shrimp L. vannamei is a species with rapid growth, high survival and price in the 
market, which makes this crustacean one of the most important resources at worldwide level. 
Item. HOM-60°C 60°C HOM-35°C 35 °C No HOM
W Day 1 (g) 0.11 ± 0.05 0.10 ± 0.03 0.10 ± 0.04 0.12 ± 0.04 0.12 ± 0.04
W Day 28 (g) 0.11 ± 0.06 0.11 ± 0.06 0.15 ± 0.06 0.20 ± 0.06 0.20 ± 0.07
Survival (%) 28 46 87 54 93
Data are presented as Mean value ± SD. W = Wet weight.
Table 2. Octopus bimaculoides juvenile growth and survival during food and HOM treatment assessment.
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Nonetheless, the production of this important resource has been hindered by recurrent epizo-
otic outbreaks and sudden mortalities caused by pathogen microorganisms. To face the chal-
lenge, several chemical and antibiotic products have usually been applied whose prophylactic 
application was initially an effective strategy. However, they have caused the development 
of resistant bacteria making it necessary to reduce their application. These problems have 
led the shrimp industry to explore and develop new and more strategies, as effective as or 
better than antibiotics, eco-friendly and with long-term sustainability. Previous studies have 
indicated that homoeopathic medicines stimulated the immune system and caused specific 
organic responses [31, 32]. Therefore, we evaluated the effect of homoeopathic medicines in 
growth and survival of L vannamei postlarvae under controlled laboratory conditions (Trial 
1); the survival and antioxidant response through superoxide dismutase (SOD) activity in 
juveniles when challenged (1 x 106 CFU ml−1) with a pathogenic strain of V. parahaemolyticus 
(CAIM-170) at CIBNOR, in a biosecurity laboratory (Trial 2); during the production of post-
larvae in a commercial hatchery, focusing on dynamics of the bacterial populations (Trial 3); 
zootechnical (growth) results and gene expression (Trial 4); and growing-out to marketable 
size in a commercial farm (Trial 5).
Trial 1. To evaluate growth and survival of postlarvae, an experimental design was applied 
at CIBNOR with three HOM treatments: ViP-ViA (T1), PhA-SiT (T2), ViP-ViA + PhA-SiT (T3) 
and ET (T4) as control. HOM treatments were applied for 30 days, spraying liquid dynamisa-
tions in commercial pelleted food, administered ad-libitum. In general, the best results were 
obtained in T3 (T1 + T2), showing a clear synergy between T1 and T2 (Table 3).
Trial 2. To assess survival and SOD activity in juveniles, an experimental design with four 
HOM treatments: INM (T1), PaV (T2), INM-PaV (T3), ViT (T4) and NT (T5) was applied at 
CIBNOR. HOM treatments were applied to juveniles 7 days prior to challenge and 5 days 
during challenge. Liquid dynamisations were sprayed in commercial pelleted food, which 
was supplied ad-libitum, 7 days prior to and during challenge. At 70 h after the start of the 
challenge, SOD was determined in shrimp tissue. At the end of the challenge (120 h post-
infection), the shrimp treated with T2, T3 and T4, exhibited significantly higher average sur-
vival (p < 0.05) than the control group T5. Juveniles treated with T3 and T4 showed the highest 
Parameter Treatments
T1 T2 T3 T4
LI (cm) 4.64 ± 0.94 b 4.61 ± 0.94 a 3.92 ± 0.93 a 4.59 ± 0.70 a
WI (g) 2.82 ± 0.60 a 2.92 ± 0.65 b 3.15 ± 0.74 b 2.62 ± 0.53 a
DWI (g day−1) 0.018 ± 0.007 ab 0.02 ± 0.009 ab 0.052 ± 0.018 c 0.016 ± 0.007 a
GR 0.094 ± 0.020 a 0.097 ± 0.021 b 0.105 ± 0.024 c 0.087 ± 0.017 a
S (%) 99.30 97.33 99.33 98.00
Different letters in the same column, indicate significant difference (p < 0.05). Length increase (LI), weight increase (WI), 
daily weight increase (DWI), growth rate (GR), survival (S).
Table 3. Growth and survival of Litopenaeus vannamei postlarvae treated with homoeopathic treatments during an 
experimental assay at CIBNOR laboratory.
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survival with 64.43 and 56%, respectively, while all those treated with T1 and T5 died. These 
results suggested that the greatest survival of HOM-treated shrimp could have been related 
to a stimulation of their immune system, and consequently, to a greater resistance to acute 
infectious diseases associated with the genus Vibrio [32]. Regarding SOD activity, at 70 h after 
the start of the challenge, the groups treated with T1 and T2 did not show significant differ-
ences (34.48 ± 1.87 and 16.32 ± 1.22, respectively) in relation to the control group (41.63 ± 2.59) 
while T3 and T4 with a SOD activity of (86.43 ± 1.02 and 83.47 ± 5.54, respectively) exhibited 
significantly higher values than the control group (p < 0.05) (41.63 ± 2.59) (Figure 8).
Treatment T3 contained PaV used in human medicine as a tranquilliser to reduce stress and 
improve sleep, in addition to Heel-Mix (Rubiopharma®, Mexico) that contains medicines used 
for the treatment of enzymatic disorders, infectious diseases and stimulation of the body 
defences in human beings, whereas T4 is a homoeopathic medicine whose active principle is the 
venom of the scorpion Rhopalurus junceus which is an endemic species of Cuba. These results 
suggested a potential applicability of the homoeopathic medicines studied as prophylactic 
treatments to reduce stress and to improve shrimp immune response, which could help reduce 
the incidence of epizootic diseases and massive mortalities that have been a great problem for 
the industry due to economic losses associated with V. parahaemolithycus in shrimp culture.
Trial 3. A third experiment consisted of the evaluation of HOM treatments during the com-
mercial production of L. vannamei postlarvae in the facilities of the commercial hatchery 
Aquacultura Mahr in square concrete tanks with a capacity of 20 t. An experimental design 
was applied with four tanks with three HOM treatments: MaP-CaP-Fep-Zip-PhA (T1) Hes-
Sit-Cap-Pha (T1), INM-PaV-ViT-PhA (T3), and NT as the control group (T4). Liquid homoeo-
pathic dynamisations were added to commercially pulverised food given periodically for a 
24-h period (day-night). Shrimp farming has been affected by viral and bacterial diseases 
principally those associated to a highly virulent strain of V. parahaemolyticus; this problem 
is of primary interest concern [33], so this assay was intended to determine the population 
dynamics of the bacterial populations mainly Vibrio spp. Bacteriological examination of iso-
lated vibrio species depend mainly on using TCBS agar as a selective media to differentiate 
Figure 8. SOD activity in HOM-treated juvenile shrimp Litopenaeus vannamei treated with homoeopathy and then 
challenged with Vibrio parahaemolithycus.
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between sucrose and non-sucrose fermented colonies; V. alginolyticus is sucrose fermenter and 
shows yellow-coloured colonies while V. parahaemolyticus and V. vulnificus are non-sucrose 
fermenters and have green colonies [34]. Although no statistical significant (p > 0.05) differ-
ences were found in HOM-treated and non-treated PLs, positive effects were apparently 
attained with HOM treatments (Figure 9). Research must continue not only with controlled 
and multi-replicate experimental designs in the laboratory but also efforts should continue in 
commercial hatcheries even if obvious difficulties exist because production is at most the first 
priority and not necessarily compatible with a strict and traditional scientific research.
Trial 4. A fourth assessment was made also at Aquacultura Mahr hatchery. An experimental 
design was applied in six concrete tanks (20 t) with five HOM treatments: BaC-INM, Sit-INM 
(T2), HeS-INM (T3), PhA-INM (T4), PaV-INM (T5), and two NT control groups (T6 and T7). 
Liquid homoeopathic dynamisations were provided with pulverised food as vehicle. Growth in 
weight of the shrimp postlarvae was exponential with a correlation coefficient (r2) > 0.95. The best 
treatment was T5 (PaV-INM). The NT control group had the lowest growth rate and the lowest 
survival (20.2%), while in the HOM-treated groups, it was 25.6 ± 5.38% (21–34.1%) (Figure 10, 
Left). At the end of the production cycle, gene expression analyses were made at CIBNOR to 
compare HOM-treated with non-treated postlarvae. The results of gene expression related to 
the activities of the aminopeptidase (AMP), amylase (AMY), chymotrypsin (CHY) and trypsin 
(TRY) enzymes showed clear and statistically significant differences (p < 0.05; n = 30) between the 
HOM-treated and NT postlarvae (Figure 10, Right). These results confirmed a positive impact 
of the use of homoeopathic medicines in the commercial production of L. vannamei postlarvae.
Trial 5. A fourth experiment consisted of the evaluation of HOM treatments during the 
mass cultivation of L. vannamei from postlarvae to adult size in commercial facilities of 
the company BCS Camarón, a commercial shrimp farm. The evaluation was performed in 
six earthen ponds of 10 ha each, initially seeded at a density of 8 PL m−2. An experimental 
design was applied with six earthen ponds 10 ha, four ponds with HOM treatment and two 
NT ponds without homoeopathy: PhA-SiT (T1), PaV-ViT (T2), and NT as negative control 
group (T3). Liquid homoeopathic dynamisations were sprayed in commercially balanced 
food and applied in the culture ponds, each treatment component on alternate days for 
130 days. Three samplings were made: after seeding and 7 days for acclimatisation (t
1
); after 
52 days (t
52
) and after 130 days post seeding (t
130
). Growth parameters and biomass produc-
tion as body weight (BW), total length (TL) and weight gain average (WGA) were deter-
mined. As physiological health indicators, the hepatopancreatic coverage index (HCI) was 
Figure 9. Straight regression showing the increasing trends in the bacterial count of Vibrio spp. in culture seawater and 
macerate of Litopenaeus vannamei postlarvae. Petri dish with TCBS culture medium, which was previously inoculated, 
showing the presence of sucrose positive (yellow) and sucrose negative (green) colonies of the genus Vibrio.
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evaluated as a morpho-histological index variable [HCI (%) = hepatopancreatic coverage 
area/cephalothorax coverage area × 100]. From an initial time characterised by no significant 
differences in BW and TL after 130 days of culture both HOM (T1 and T2) produced the best 
growth results in BW, TL and WGA compared to NT ponds (Table 4).
The shrimp treated with PaV-VIT after 52 days of treatment (T1) achieved the highest HCI 
(32.32 ± 0.61%) and differed from PhA − SIT and un-treated control ponds. (28.34 ± 0.87%; 
26.58 ± 0.64%, respectively). At the end of the experiment (130 days), both homoeopathic treat-
ments showed better HCI; in relation to the negative control group (PhA − SIT = 33.87 ± 1.02%; 
PaV − VIT = 33.31 ± 0.77% control T3 = 26.54 ± 0.56%) as shown in Figure 11.
The positive effect of the HOM treatments evaluated in growth and morpho-histological 
index of L. vannamei could be attributable to smaller micelle and higher activity in water with 
Growth variables Experimental groups (Two 10 h ponds each)
T1 T3 T2
BW T
0
 (7 days) 2.47 ± 0.06 a 2.43 ± 0.06 a 2.52 ± 0.07 a
BW T
1
 (52 days) 16.79 ± 0.22 a 16.02 ± 0.19 a 18.83 ± 0.21 b
BW T
2
 (130 days) 20.08 ± 0.18 a 18.59 ± 0.17 b 23.90 ± 0.29 c
TL T
0
 (7 days) 7.13 ± 0.05 a 7.08 ± 0.05 a 7.06 ± 0.06 a
TL T
1
 (52 days) 13.89 ± 0.05 a 13.71 ± 0.06 a 14.31 ± 0.06 b
TL T
2
 (130 days) 15.02 ± 0.05 a 14.66 ± 0.05 b 15.81 ± 0.06 c
WGA T
1
 (52 days) 14.37 ± 0.27 ab 13,59 ± 0.05 a 15,72 ± 0.78 b
WGA T
2
 (130 days) 17.58 ± 0.26 a 16,41 ± 0.14 b 21,08 ± 0.64 c
Body weight (BW), Total length (TL), weight gain average (WGA). Values within the same row with different letters 
represent significant differences (p < 0.05).
Table 4. Growth of Litopenaeus vanamei treated with homoeopathy while cultured in semi-intensive system in a 
commercial shrimp farm (BCS Camarón Farm; six earthen ponds, 10 ha).
Figure 10. Growth in weight (left) and gene expression (right) in Litopenaeus vannamei postlarvae or adult treated and 
with homoeopathic medicines in a commercial shrimp hatchery (Acuacultura Mahr). Aminopeptidase (AMP), amylase 
(AMY), chymotrypsin (CHY), trypsin (TRY).
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nanoparticle content [35]. The presence of nanoparticles has been demonstrated in highly 
homoeopathic ultra-diluted medicines [8]. On the other hand, the same homoeopathic medi-
cines used in shrimp ponds, (PaV, PhA, SIT and ViT) outperformed antibiotics in juvenile scal-
lop A. ventricosus [23] These results enhanced the evidences that aquacultural homoeopathy has 
applicability in shrimp commercial culture to improve the productivity of the shrimp industry.
3. Conclusion
One of the most promising and novel fields that strengthen the immune system in marine 
organisms is the use of immunostimulants that are natural compounds modulating the 
immune system and increasing resistance of the host against disease mainly those caused 
by bacteria [18]. Regarding immunostimulants, homoeopathy has been proposed as a 
novel alternative in aquaculture practices to improve health and strengthen the organism’s 
immune response [5, 23]. The production of marine mollusc, shrimp and fish around the 
world still challenged every year by the propagation and emergence of new diseases, mainly 
those related to viruses and bacteria such as Vibrio spp. and Aeromonas spp., which are treated 
with conventional methods as antibiotics [2, 14]. The findings in our research suggested that 
homoeopathic medicines have a great potential to increase health and performance in marine 
mollusc including bivalves and octopus, shrimp and marine fish.
Findings in the scallop A. ventricosus support the fact that homoeopathic medicines do not 
act directly over the disease-cause per-se, killing the bacteria or removing the stressing agent 
but enhancing the capacity of the HOM-treated organisms to resist the infection or overpass 
stressful conditions. Some results in molluscs have shown a greater effect of homoeopathic 
medicines on survival than on growth of larvae and seeds. However, it is necessary to con-
sider that greater survival implies maintaining a higher density in larval culture and that 
not only larvae of larger size are able to settle and become marketable seeds with a good 
performance in the field. From a commercial point of view, it is more important to attain big-
ger biomass of successfully setting larvae even if small sized because independently of their 
Figure 11. Hepatopancreatic coverage index (HCI %) of adult shrimp in a commercial shrimp farm (earth ponds 10 h) 
treated with homoeopathic medicines.
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size, all larvae are capable and competent for setting process and seed sales. This work has 
also contributed to the knowledge of octopus for aquaculture purposes since this organism is 
an important fishery in Mexico with precocious development and high growth rates. For this 
and all other species, homoeopathic medicines are not intended as food additives; on the con-
trary, they contribute to acquire a better internal homeostasis, and as a consequence, a better 
digestive enzyme function and nutrition, and an enhanced immune system, despite of lacking 
differences in growth parameters. Regarding fish culture, this industry is increasing with time 
in Mexico but especially marine fish, which represents a great opportunity to improve fish 
culture by using homoeopathy; as it was demonstrated in this work, it participates at diverse 
developmental stages, enhancing fish health and growth performance.
To date, overall results are positive and suggest that homoeopathy is a natural, viable and 
eco-friendly treatment to reduce the use of disinfectants and chemotherapeutics, including 
antibiotics, in mollusc, shrimp and marine fish industries, to reduce stress, improve nutrition 
and immune response, to increase their resistance to any of the various pathogenic strains 
of bacteria and viruses that have come to hatcheries and farms and will continue to reach 
them worldwide. Future experiments are being planned at CIBNOR to elucidate the role that 
homoeopathic medications could play in these organisms.
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